Articles - Page 2 of 5 - Tumori Journal

Time trends of cancer incidence in young adults (20-49 years) in Italy. A population – based study, 2008-2017

Research ArticleBy Alessia Zini November 15, 2024

To evaluate short-term (2008–2017) cancer incidence trends in Italy for individuals aged 20-49 years by sex and cancer type. Observational study from population-based data collected by 20 Italian Cancer Registries, covering 33% of the Italian population. The age-standardized incidence rates (ASRs), overall and stratified by area, sex, cancer site or type, and major age groups (i.e., 20-39, 40-49), were computed.

Details

Volume 110 Issue 2_suppl, November 2024

Research ArticleBy Alessia Zini November 10, 2024

Read the latest issue. This issue contains the Abstract Book for XXVI AIOM National Congress, 8-10 November 2024, Rome (Italy). Guest Editor: Francesco Perrone. This issue includes AIOM Abstract.

Details

Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer

Research ArticleBy Alessia Zini November 6, 2024

The need for predictive factors regarding the response to immune checkpoint inhibitors (ICIs) is increasing. Recent research indicates that an enhanced response to ICIs is associated with a higher body mass index (BMI). This study aims to evaluate the relationship between response to ICIs and BMI in solid tumors.

Details

KRAS inhibitors in drug resistance and potential for combination therapy

Review ArticleBy Alessia Zini November 6, 2024

Kirsten Rat Sarcoma (KRAS) is a potent target for cancer therapy because it acts as a signaling hub, engaging in various signaling pathways and regulating a number of cellular functions like cell differentiation, proliferation, and survival. Recently, an emergency approval from the US-FDA has been issued for KRASG12C inhibitors (sotorasib and adagrasib) for metastatic lung cancer treatment.

Details

High throughput sequencing reveals alterations in B cell receptor repertoires associated with the progression of hepatic cirrhosis to hepatocellular carcinoma

Research ArticleBy Alessia Zini October 31, 2024

Hepatocellular carcinoma (HCC) is developed as a consequence of chronic liver cirrhosis, and both diseases are difficult to diagnose and differentiate. Accurate noninvasive biomarkers for HCC and liver cirrhosis are urgently needed. Here we used high-throughput sequencing to characterize the B cell receptor (BCR) repertoires from 36 HCC tumor samples and 10 liver cirrhosis (LC) tissue biopsies to understand the immune alterations during hepatic carcinogenesis.

Details

Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936)

Research ArticleBy Alessia Zini October 27, 2024

There is debate about the optimal management of borderline resectable (bRe) and resectable (Re) pancreatic ductal adenocarcinoma (PDAC). Both preclinical and clinical evidence showed that carbon ion radiotherapy (CIRT) produces superior control on radioresistant histologies compared to conventional photon beam radiotherapy (RT).

Details

Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study

Research ArticleBy Alessia Zini October 27, 2024

Literature is lacking when it comes to oncology nursing attitudes in clinical trial involvement. To assess how Italian oncology nurses perceived their attitudes in clinical trials involvement. An on-line cohort observational study was carried out. Data collected included: sex, years of work experience in oncology field and 10 items assessing participants’ self-perceptions of their attitudes in clinical trials.

Details

Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study

Research ArticleBy Alessia Zini October 25, 2024

This study aimed to compare the incidence of fat necrosis after accelerated partial breast irradiation (APBI) vs hypofractionated whole breast irradiation (WBI) in patients with early-stage breast cancer. Data from early-stage breast cancer patients who underwent breast-conserving surgery and adjuvant radiotherapy between 2009 and 2022 were retrospectively collected.

Details

Proton therapy for pediatric malignancies: Indications and challenges focusing on the oncological landscape

EditorialBy Alessia Zini October 15, 2024

Advances in therapeutic techniques and multimodal approaches have significantly improved the success rates of treatment for pediatric malignancies, with cure rates now close to 80%. This has led to an increase in long-term survival, with 0.10-0.15% of the general population being survivors of childhood cancer.

Details

Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria

Research ArticleBy Alessia Zini October 14, 2024

We conducted an online survey to investigate oncologists’ clinical practices and views on palliative care at the end of life in the Italian region of Liguria. The survey included 29 items divided into three sections: participant characteristics (n=6), hospital resources and practices (n=11), participant practices and views (n=12).

Details